Kolexia
Mohand-Said Saddek Ophtalmologie
Mohand-Said Saddek
Ophtalmologie
Cabinet libéral
Neuilly-Plaisance, France
127 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Rétinite pigmentaire Dystrophies des cônes et des batonnets Rétinite Dystrophie des cônes Dégénérescence maculaire Cécité Maladie de Stargardt Dystrophies rétiniennes Dégénérescence de la rétine

Collaborateurs

Voir plus
Sahel Jose-Alain
Sahel Jose-Alain
Hôpital Quinze-Vingts , Paris, France
Audo Isabelle
Audo Isabelle
Hôpital Quinze-Vingts , Paris, France
Paques Michel
Paques Michel
Hôpital Quinze-Vingts , Paris, France
Dollfus Helene
Dollfus Helene
Hôpital Hautepierre, Strasbourg, France

Industries

Voir plus
Novartis
4 collaboration(s)
Dernière en 2021
Wicab
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Variants in UBAP1L lead to autosomal recessive rod-cone and cone-rod dystrophy.
Genetics in medicine : official journal of the American College of Medical Genetics   28 janvier 2024
PRIMA FS: Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration
Essai Clinique (Pixium Vision SA)   23 janvier 2024
Development and validation of a novel mobility test for rod-cone dystrophies, from reality to virtual reality.
American journal of ophthalmology   10 juillet 2023
Extensive myelinated retinal nerve fibres and bilateral foveal hypoplasia: A specific clinical entity.
Acta ophthalmologica   05 août 2022
Retrospective Natural History Study of -Related Cone- and Cone-Rod Dystrophies While Expanding the Mutation Spectrum of the Disease.
International journal of molecular sciences   28 juin 2022
Retinal Phenotype of Patients with CLRN1-Associated Usher 3A Syndrome in French Light4Deaf Cohort.
Investigative ophthalmology & visual science   02 mai 2022
Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration: A Phase I/IIA Dose Escalation Safety Study of Subretinally Injected SAR422459, Administered to Patients With Stargardt's Macular Degeneration
Essai Clinique (Sanofi)   30 mars 2022
Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5.
American journal of ophthalmology   04 mars 2022
Simultaneous perception of prosthetic and natural vision in AMD patients.
Nature communications   26 janvier 2022
Argus® II Retinal Stimulation System Feasibility Protocol
Essai Clinique (Second Sight Medical Products)   11 janvier 2022